Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMS
AMS logo

AMS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy American Shared Hospital Services (AMS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.350
1 Day change
52 Week Range
3.110
Analysis Updated At
2026/03/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

American Shared Hospital Services (AMS) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock shows bearish technical indicators, weak financial performance, and lacks positive catalysts. It is better to hold off on investing until there are signs of improvement in financials, technicals, or external catalysts.

Technical Analysis

The stock is currently in a bearish trend. The MACD is negatively expanding, RSI indicates the stock is oversold at 10.718, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.886 and 1.82, with resistance at 1.993 and 2.1. The stock has an 80% chance of declining -1.25% in the next week but a 9.76% chance of increasing in the next month.

Positive Catalysts

  • NULL identified. No recent news or significant insider/hedge fund activity. Gross margin improved by 13.03% YoY in the latest quarter.

Neutral/Negative Catalysts

  • MACD and moving averages indicate a bearish trend. Lack of recent news or external positive catalysts.

Financial Performance

In Q3 2025, revenue increased by 2.46% YoY to $7,171,000, but net income dropped significantly by -91.79% YoY to -$17,000. EPS fell to 0, down -100% YoY. Gross margin improved to 22.12%, up 13.03% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

Wall Street analysts forecast AMS stock price to rise
Analyst Rating
0
Wall Street analysts forecast AMS stock price to rise
Buy
Hold
Sell
0
Current: 1.350
sliders
Low
0
Averages
0
High
0
0
Current: 1.350
sliders
Low
0
Averages
0
High
0
JPMorgan
Overweight
to
NULL
downgrade
AI Analysis
2025-12-04
Reason
JPMorgan
Price Target
AI Analysis
2025-12-04
downgrade
Overweight
to
NULL
Reason
JPMorgan lowered the firm's price target on Amadeus IT Group to EUR 71 from EUR 75 and keeps an Overweight rating on the shares.

People Also Watch